Cargando…
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system
Cases of progressive multifocal leukoencephalopathy can occur in patients treated with the B cell depleting anti-CD20 antibody, rituximab, highlighting the importance of B cell surveillance of the central nervous system (CNS). The lymphoid chemokine, CXCL13, is critical for B cell recruitment and fu...
Autores principales: | Rainey-Barger, Emily K., Rumble, Julie M., Lalor, Stephen J., Esen, Nilufer, Segal, Benjamin M., Irani, David N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135968/ https://www.ncbi.nlm.nih.gov/pubmed/20933590 http://dx.doi.org/10.1016/j.bbi.2010.10.002 |
Ejemplares similares
-
Type-I Interferons Suppress Microglial Production of the Lymphoid Chemokine, CXCL13
por: Esen, Nilufer, et al.
Publicado: (2014) -
Regulated Production of CXCL13 within the Central Nervous System
por: Irani, David N.
Publicado: (2016) -
Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice
por: Esen, Nilufer, et al.
Publicado: (2012) -
CXCL13 expressed on inflamed cerebral blood vessels recruit IL-21 producing T(FH) cells to damage neurons following stroke
por: Rayasam, Aditya, et al.
Publicado: (2022) -
The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis
por: Rupprecht, Tobias A, et al.
Publicado: (2009)